ACTINIUM PHARMACEUTICALS, INC. Derivative, Gain (Loss) on Derivative, Net
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Derivative, Gain (Loss) on Derivative, Net of $9.08 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Income Statement › Other Income
us-gaap:DerivativeGainLossOnDerivativeNet · last filed 2019-03-15
- ACTINIUM PHARMACEUTICALS, INC. derivative, gain (loss) on derivative, net for the quarter ending 2018-03-31 was $9.08K.
- ACTINIUM PHARMACEUTICALS, INC. derivative, gain (loss) on derivative, net for the quarter ending 2017-12-31 was $38.41K, a 70.71% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. derivative, gain (loss) on derivative, net for the quarter ending 2017-09-30 was $372.12K, a 25.99% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. derivative, gain (loss) on derivative, net for the quarter ending 2017-06-30 was $149.59K, a 49.37% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. derivative, gain (loss) on derivative, net for fiscal 2017 was $304.12K, a 87.98% decline from fiscal 2016.
- ACTINIUM PHARMACEUTICALS, INC. derivative, gain (loss) on derivative, net for fiscal 2016 was $2.53M, a 33.62% decline from fiscal 2015.
- ACTINIUM PHARMACEUTICALS, INC. derivative, gain (loss) on derivative, net for fiscal 2015 was $3.81M.
- ACTINIUM PHARMACEUTICALS, INC. derivative, gain (loss) on derivative, net for fiscal 2014 was -$2.21M.
| Period end | Derivative, Gain (Loss) on Derivative, Net 3 month | Derivative, Gain (Loss) on Derivative, Net 6 month | Derivative, Gain (Loss) on Derivative, Net 9 month | Derivative, Gain (Loss) on Derivative, Net 12 month | Derivative, Gain (Loss) on Derivative, Net 12 month as first filed | Derivative, Gain (Loss) on Derivative, Net 151 month | Derivative, Gain (Loss) on Derivative, Net 154 month | Derivative, Gain (Loss) on Derivative, Net 157 month | Derivative, Gain (Loss) on Derivative, Net 160 month | Derivative, Gain (Loss) on Derivative, Net 163 month | Derivative, Gain (Loss) on Derivative, Net 166 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $9.08K 10-Q · filed 2018-05-10 | $47.48K derived: sum of 2 quarters · filed 2019-03-15 | $419.60K derived: sum of 3 quarters · filed 2019-03-15 | $569.19K derived: sum of 4 quarters · filed 2019-03-15 | |||||||
| 2017-12-31 | $38.41K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $410.53K derived: sum of 2 quarters · filed 2019-03-15 | $560.12K derived: sum of 3 quarters · filed 2019-03-15 | $304.12K 10-K · filed 2019-03-15 | |||||||
| 2017-09-30 | $372.12K 10-Q · filed 2018-11-09 | $521.71K derived: sum of 2 quarters · filed 2018-11-09 | $265.71K 10-Q · filed 2018-11-09 | $396.84K derived: sum of 4 quarters · filed 2019-03-15 | |||||||
| 2017-06-30 | $149.59K 10-Q · filed 2018-08-09 | -$106.40K 10-Q · filed 2018-08-09 | $24.72K derived: sum of 3 quarters · filed 2019-03-15 | $527.50K derived: sum of 4 quarters · filed 2019-03-15 | |||||||
| 2017-03-31 | -$256.00K 10-Q · filed 2018-05-10 | -$124.87K derived: sum of 2 quarters · filed 2019-03-15 | $377.91K derived: sum of 3 quarters · filed 2019-03-15 | $673.37K derived: sum of 4 quarters · filed 2019-03-15 | |||||||
| 2016-12-31 | $131.13K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $633.90K derived: sum of 2 quarters · filed 2019-03-15 | $929.37K derived: sum of 3 quarters · filed 2019-03-15 | $2.53M 10-K · filed 2019-03-15 | |||||||
| 2016-09-30 | $502.78K 10-Q · filed 2017-11-03 | $798.24K derived: sum of 2 quarters · filed 2017-11-03 | $2.40M 10-Q · filed 2017-11-03 | $779.04K derived: sum of 4 quarters · filed 2018-03-16 | |||||||
| 2016-06-30 | $295.46K 10-Q · filed 2017-08-04 | $1.90M 10-Q · filed 2017-08-04 | $276.26K derived: sum of 3 quarters · filed 2018-03-16 | $970.47K derived: sum of 4 quarters · filed 2018-03-16 | |||||||
| 2016-03-31 | $1.60M 10-Q · filed 2017-05-15 | -$19.20K derived: sum of 2 quarters · filed 2018-03-16 | $675.01K derived: sum of 3 quarters · filed 2018-03-16 | $617.34K derived: sum of 4 quarters · filed 2018-03-16 | |||||||
| 2015-12-31 | -$1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | -$926.39K derived: sum of 2 quarters · filed 2018-03-16 | -$984.06K derived: sum of 3 quarters · filed 2018-03-16 | $3.81M 10-K · filed 2018-03-16 | |||||||
| 2015-09-30 | $694.21K 10-Q · filed 2016-10-28 | $636.54K derived: sum of 2 quarters · filed 2016-10-28 | $5.43M 10-Q · filed 2016-10-28 | $6.88M derived: sum of 4 quarters · filed 2017-03-16 | |||||||
| 2015-06-30 | -$57.67K 10-Q · filed 2016-07-29 | $4.74M 10-Q · filed 2016-07-29 | $6.19M derived: sum of 3 quarters · filed 2017-03-16 | $7.15M derived: sum of 4 quarters · filed 2017-03-16 | |||||||
| 2015-03-31 | $4.80M 10-Q · filed 2016-05-10 | $6.24M derived: sum of 2 quarters · filed 2017-03-16 | $7.21M derived: sum of 3 quarters · filed 2017-03-16 | $15.15M derived: sum of 4 quarters · filed 2017-03-16 | |||||||
| 2014-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $2.42M derived: sum of 2 quarters · filed 2017-03-16 | $10.35M derived: sum of 3 quarters · filed 2017-03-16 | -$2.21M 10-K · filed 2017-03-16 | |||||||
| 2014-09-30 | $967.89K 10-Q · filed 2015-10-30 | $8.91M derived: sum of 2 quarters · filed 2015-10-30 | -$3.65M 10-Q · filed 2015-10-30 | -$8.05M derived: sum of 4 quarters · filed 2016-03-11 | |||||||
| 2014-06-30 | $7.94M 10-Q · filed 2015-08-07 | -$4.62M 10-Q · filed 2015-08-07 | -$9.02M derived: sum of 3 quarters · filed 2016-03-11 | -$8.83M derived: sum of 4 quarters · filed 2016-03-11 | |||||||
| 2014-03-31 | -$12.56M 10-Q · filed 2015-05-08 | -$16.96M derived: sum of 2 quarters · filed 2016-03-11 | -$16.77M derived: sum of 3 quarters · filed 2016-03-11 | -$18.07M derived: sum of 4 quarters · filed 2016-03-11 | -$16.04M 10-Q · filed 2014-05-12 | ||||||
| 2013-12-31 | -$4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | -$4.21M derived: sum of 2 quarters · filed 2016-03-11 | -$5.51M derived: sum of 3 quarters · filed 2016-03-11 | -$4.18M 10-K · filed 2016-03-11 | -$3.48M 10-K · filed 2014-02-28 | ||||||
| 2013-09-30 | $189.35K 10-Q · filed 2014-10-31 | -$1.12M derived: sum of 2 quarters · filed 2014-10-31 | $216.11K 10-Q · filed 2014-10-31 | $1.19M derived: sum of 4 quarters · filed 2014-10-31 | $915.50K 10-Q · filed 2013-11-14 | ||||||
| 2013-06-30 | -$1.31M 10-Q · filed 2014-08-12 | $26.76K 10-Q · filed 2014-08-12 | $999.79K derived: sum of 3 quarters · filed 2014-08-12 | $705.41K derived: sum of 4 quarters · filed 2014-08-12 | $726.15K 10-Q · filed 2013-08-13 | ||||||
| 2013-03-31 | $1.33M 10-Q · filed 2014-05-12 | $2.31M derived: sum of 2 quarters · filed 2014-05-12 | $2.01M derived: sum of 3 quarters · filed 2014-05-12 | $1.61M derived: sum of 4 quarters · filed 2014-05-12 | $2.03M 10-Q · filed 2013-05-15 | ||||||
| 2012-12-31 | $973.02K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $678.64K derived: sum of 2 quarters · filed 2014-02-28 | $276.12K derived: sum of 3 quarters · filed 2014-02-28 | $685.42K 10-K · filed 2014-02-28 | -$685.42K 10-K · filed 2013-03-29 | -$699.39K 10-K · filed 2013-03-29 | |||||
| 2012-09-30 | -$294.38K 10-Q · filed 2013-11-14 | -$696.90K derived: sum of 2 quarters · filed 2013-11-14 | -$287.60K 10-Q · filed 2013-11-14 | ||||||||
| 2012-06-30 | -$402.52K 10-Q · filed 2013-08-13 | $6.78K 10-Q · filed 2013-08-13 | |||||||||
| 2012-03-31 | $409.30K 10-Q · filed 2013-05-15 | ||||||||||
| 2011-12-31 | -$13.97K 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |